Amantadine (GOCOVRI)
Influenza A M2 Protein Inhibitor class · 19 generic manufacturers · 22 ANDAs filed at FDA.
$190.5M in CY2024 Part D spend849K claims · 200K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Amantadine used for?
Amantadine is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Amantadine?
Yes. 22 ANDAs filed at FDA, 19 generic manufacturers currently shipping.
How much does my plan pay for Amantadine?
Across 329 Part D plans, Amantadine averages $0.124/unit (NADAC). Lowest available: $0.050/unit. Highest in distribution: $0.143/unit.
Is Amantadine on the FDA shortage list?
Amantadine has been discontinued by its manufacturer(s).
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.